These SKOV3-Ly75 KD cells directly enhanced EOC initiation, tumor spread and resistance to treatment following intra-bursal IB injection in severe combined immunodeficiency (SCID) mice, compared to mesenchymal-type SKOV3 cells. The gene discussed is LY75; the disease is neoplasm.